MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-02713-5

Медицинская библиотека · Scientific reports · 2025

Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma.

Sitthirak Sirinya, Roytrakul Sittiruk, Wangwiwatsin Arporn, Namwat Nisana, Klanrit Poramate, Dokduang Hasaya, Sa-Ngiamwibool Prakasit, Titapan Attapol, Jareanrat Apiwat, Thanasukarn Vasin, Khuntikeo Natcha, Boulter Luke, Loilome Watcharin

СтатьяПеревод пока не подготовлен

Аннотация

Cholangiocarcinoma (CCA), a neoplasm arising from biliary epithelial cells, is particularly widespread in Southeast Asia, with northeastern Thailand exhibiting the greatest prevalence attributed to Opisthorchis viverrini infection. This malignancy exhibits considerable molecular heterogeneity, leading to therapeutic resistance and recurrence. Comprehending its molecular mechanisms is essential for enhancing diagnostic and treatment approaches. Our research utilized multi-region LC-MS/MS proteomic analysis to investigate intratumor heterogeneity (ITH) in CCA. We examined 52 tumor areas and 13 neighboring tissues from 13 patients, concentrating on protein profiling, pathway analysis, differential protein expression, and the identification of shared and unique protein signatures. The findings indicated considerable inter-patient proteome variability, characterized by markedly distinct protein expressions among individuals, aligning with prior cancer research. Intra-tumor heterogeneity was apparent, with merely 18 proteins common to all tumor areas and patients, underscoring the intricacy of CCA. Significantly, the common proteins were associated with metabolic reprogramming and oxidative stress pathways, indicating possible indicators and therapeutic targets. This work highlights the significant proteome variability in CCA at both intra-tumor and inter-patient levels, underscoring the necessity for customized therapeutic approaches to tackle the disease's complexity and improve treatment outcomes.

Для цитирования: Sitthirak Sirinya, Roytrakul Sittiruk, Wangwiwatsin Arporn, Namwat Nisana, Klanrit Poramate, Dokduang Hasaya, Sa-Ngiamwibool Prakasit, Titapan Attapol, Jareanrat Apiwat, Thanasukarn Vasin, Khuntikeo Natcha, Boulter Luke, Loilome Watcharin. Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma.. Scientific reports. 2025. DOI: 10.1038/s41598-025-02713-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.